Cargando…
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
BACKGROUND: This prospective phase I/II trial assessed feasibility and efficacy of dose-escalated definitive chemoradiation after induction chemotherapy in locally advanced esophageal cancer. Primary study endpoint was loco-regional progression-free survival at 1 year. METHODS: Eligible patients rec...
Autores principales: | Pöttgen, C., Gkika, E., Stahl, M., Abu Jawad, J., Gauler, T., Kasper, S., Trarbach, T., Herrmann, K., Lehmann, N., Jöckel, K.-H., Lax, H., Stuschke, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988964/ https://www.ncbi.nlm.nih.gov/pubmed/33757534 http://dx.doi.org/10.1186/s13014-021-01788-4 |
Ejemplares similares
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
por: Pöttgen, Christoph, et al.
Publicado: (2015) -
Purinergic signaling is enhanced in the absence of UT‐A1 and UT‐A3
por: Himmel, Nathaniel J., et al.
Publicado: (2020) -
Structural characterization of human urea transporters UT-A and UT-B and their inhibition
por: Chi, Gamma, et al.
Publicado: (2023) -
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
por: Guberina, Nika, et al.
Publicado: (2022) -
Symphonie en ut Roma ; Patrie /
por: Bizet, Georges, 1838-1875
Publicado: (1994)